4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
Altogen Biosystems(授权代理)
主营:主营:高分子化学,分子和细胞生物学,转染试剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_kits > Altogen/NTRA-2转染试剂盒(胚胎癌)/1.5 ml CRISPR/2186
商品详细Altogen/NTRA-2转染试剂盒(胚胎癌)/1.5 ml CRISPR/2186
Altogen/NTRA-2转染试剂盒(胚胎癌)/1.5 ml CRISPR/2186
Altogen/NTRA-2转染试剂盒(胚胎癌)/1.5 ml CRISPR/2186
商品编号: 2186
品牌: Altogen Biosystems
市场价: ¥15660.00
美元价: 9396.00
产地: 美国(厂家直采)
公司:
产品分类: 其它检测试剂盒
公司分类: Other_kits
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Description

Product Availability: In Stock (delivery within 2-3 business days, no extra charge for drop-shipping).

Ordering: To place an order via credit card or PO use Add to Cart button (creating an account is not required).


Transfection Reagent for NTERA-2 Cells (Embryonal Carcinoma Cells, CRL-1973)

  • Two component formulation enhances lipid mediated transfection efficiency
  • Optimized easy-to-use transfection protocol provided for transfection of siRNA, DNA, mRNA, and microRNA
  • Kit includes Transfection Enhancer reagent and recommended transfection protocol
  • Reproducible transfection results
  • Download in vitro NTERA2 transfection protocol: [PDF]
  • Download NTERA2 CRISPR/Cas9 transfection protocol: [PDF]
  • Download PowerPoint presentation for NTERA2 cells transfection kit: [PPT]
  • Developed and manufactured by Altogen Biosystems
Transfection Efficiency:

Reagent exhibits at least 76% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.

Transfection Protocol and MSDS:

Download Altogen Biosystems NTERA2 Transfection Protocol: [PDF]

Download MSDS: [PDF]

NTERA-2 Cell Line:

Embryonal carcinomas have proven to be invaluable models for studying the mechanisms that control differentiation of cells during embryogenesis in vitro. The NTERA-2 cell line is considered a well-characterized system of ectodermal differentiation. NTERA-2 cells can be used to study the early stages of human neurogenesis as they display developmental and biochemical properties similar to embryonic cells. The NTERA-2 cl.D1 cell line was established from the parental NTERA-2 cell line after a xenograft of a 22-year-old Caucasian male with malignant pluripotent embryonic carcinoma of the testis. This cell line has unique properties, making it useful for studying of certain types of testicular cancer. These cells exhibit high activity expression of N-myc oncogene. The cell line contains untreated cells with resistance to HCMV, and HIV-1. NTERA-2 cl.D1 exhibits an epithelial-like morphology, though there is more variety than in other cell lines due to the high differentiation of these cells. Altogen Biosystems manufactures lipid-based transfection kit optimized for NTERA-2 cells that can be utilized for both transient transfection and development of stable NTERA-2 cell lines and commonly used for life sciences laboratory research studies.

Data:

NTERA2 Transfection Reagent

Figure 1. siRNAs targeting Lamin A/C mRNA or non-silencing control siRNA were transfected into NTERA-2 cells following the recommended protocol. At 48 hours post-transfection the cells were analyzed by qRT-PCR for Lamin A/C gene expression levels. 18S rRNA levels were used to normalize the Lamin A/C data. Values are normalized to untreated sample. Data are means ± SD (n=4).

NTERA2-cells-transfection-protocol

Figure 2. Protein expression of Lamin A in NTERA-2 cells. DNA plasmid expressing Lamin A or siRNA targeting Lamin A were transfected into NTERA-2 cells following Altogen Biosystems transfection protocol. At 72 hours post-transfection the cells were analyzed by Western Blot for protein expression levels (normalized by total protein, 10 µg of total protein loaded per each well). Untreated cells used as a negative control.

Request a Quote for
NTERA-2 Transfection Kit

Altogen Biosystems:
Altogen Biosystems is a life sciences company that offers cell type-specific and pre-optimized transfection products, electroporation kits, and in vivo delivery reagents. Advanced formulation of reagents and optimized transfection protocols provide efficient intracellular delivery of protein, DNA, mRNA, shRNA and siRNA molecules. Read more about transfection technology at Altogen’s Transfection Resource.

Altogen Labs Research Services:

Altogen Labs provides GLP-compliant contract research studies for pre-clinical research, IND applications, and drug development. Biology CRO services include: Xenograft models (30+), development of stable cell lines, ELISA assay development, cell-based and tissue targeted RNAi studies, safety pharm/tox assays, and other studies (visit AltogenLabs.com).

Volume Options:

  • 0.5 ml (Catalog #6875)
  • 1.5 ml (Catalog #6876)
  • 1.5 ml CRISPR (Catalog #2186)
  • 8.0 ml (Catalog #7075)
品牌介绍
Altogen Biosystems全国代理部分产品列表: 货号 产品 规格 价格(美元) 5030       1703 A204 Transfection Reagent (Rhabdomyosarcoma) 0.5ml 170 1704 A204 Transfection Reagent (Rhabdomyosarcoma) 1.5ml 348 窗体顶端 窗体底端   2101 A204 Transfection Reagent (Rhabdomyosarcoma) 1.5ml CRISPR 548 窗体顶端 窗体底端   7018 A204 Transfection Reagent (Rhabdomyosarcoma) 8.0ml 1044 窗体顶端 窗体底端   1167 A375 Cells Transfection Reagent (CRL-1619) 0.5ml 195 1168 A375 Cells Transfection Reagent (CRL-1620) 1.5ml 427 2102 A375 Cells Transfection Reagent (CRL-1621) 1.5ml CRISPR 627 1169 A375 Cells Transfection Reagent (CRL-1622) 8.0ml 1281 5030 Nanoparticle In Vivo Transfection Reagent 0.5 ml - 10 injections  445 5010 LIPID In Vivo Transfection Reagent 0.5 ml - 10 injections 405 5040 PEG-Liposome In Vivo Transfection Reagent 0.5 ml - 10 injections 465 5020 POLYMER In Vivo Transfection Reagent 0.5 ml - 10 injections 425 5050 Pancreas In Vivo Transfection Kit 0.5 ml - 10 injections  495 5060 Liver In Vivo Transfection Kit 0.5 ml - 10 injections  495 5070 Kidney In Vivo Transfection Kit 0.5 ml - 10 injections  495 1721 BMS2 Transfection Reagent (Bone Marrow Cells) 0.5 ml  231 6345 C6 Transfection Reagent (Glioma Cells, CCL-107) 0.5 ml  199 6803 DLD-1 Transfection Reagent (Colon Cancer, CCL-221) 0.5 ml  201 1775 HUH-7 Transfection Reagent (Liver Cancer Cells) 0.5 ml  179